Search

Displaying results 7891 - 7900 of 10000 in total
  1. Drug

    PF-477736

    go.drugbank.com/drugs/DB12611
    Investigational

    PF-00477736 has been used in trials studying the treatment of Neoplasms.

  2. Drug

    Vestipitant

    go.drugbank.com/drugs/DB11949
    Investigational

    Vestipitant has been investigated for the treatment of Tinnitus.

    Categories: Neurokinin-1 Receptor Antagonists
  3. Drug

    Enecadin

    go.drugbank.com/drugs/DB13032
    Investigational

    Enecadin has been investigated for the treatment of Stroke.

  4. Drug

    Vinpocetine

    go.drugbank.com/drugs/DB12131
    Investigational

    Vinpocetine has been investigated for the treatment of Epilepsy.

  5. Drug

    GW-870086

    go.drugbank.com/drugs/DB12322
    Investigational

    GW870086X has been investigated for the treatment of ASTHMA.

  6. Drug

    Ipamorelin

    go.drugbank.com/drugs/DB12370
    Investigational

    Ipamorelin has been investigated for the treatment of Ileus.

  7. Drug

    Modufolin

    go.drugbank.com/drugs/DB12676
    Investigational

    Modufolin is under investigation for the treatment of Osteosarcoma.

  8. Drug

    Dichlorophen

    go.drugbank.com/drugs/DB11396
    InvestigationalVet approved

    Dichlorophen is an antimicrobial agent shown to exert activity against cestodes, protozoa, fungi, and bacteria. … It is often combined with toluene to remove parasites including ascarids, tapeworm, and hookworm from dogs and cats.

  9. Drug

    AMP-101

    go.drugbank.com/drugs/DB18253
    Experimental

    AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human Dok-7 protein. It is under investigation for the treatment of Dok-7-associated myasthenia.

    Synonyms: Adeno-associated virus serotype 9 vector encoding the Dok7 protein
  10. Drug

    Trebananib

    go.drugbank.com/drugs/DB12056
    Investigational

    Trebananib is under investigation for the treatment of Ovarian Cancer, Peritoneal Cancer, and Fallopian Tube Cancer. … Trebananib has been investigated for the treatment of Cancer, Oncology, Carcinoma, Metastases, and Colon Cancer, among others.